So far in 2026, biotech deals amounted to $106 billion over 201 transactions, according to PitchBook data. That momentum in dealmaking comes despite an interest rate environment that has turned for the worse following the Iran war and inflationary impacts. Read more: https://t.co/qRvlE95A6L

So far in 2026, biotech deals amounted to $106 billion over 201 transactions, according to PitchBook data.

That momentum in dealmaking comes despite an interest rate environment that has turned for the worse following the Iran war and inflationary impacts.

Read more: https://t.co/qRvlE95A6L